Neovasc Inc.
NVCN
NVCN was delisted on the 10th of April, 2023.
11 hedge funds and large institutions have $305K invested in Neovasc Inc. in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 2 closing their positions.
67% more capital invested
Capital invested by funds: $183K → $305K (+$122K)
8% less funds holding
Funds holding: 12 → 11 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$21.8K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$946 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$15.7K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$8.41K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$4.89K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1K |
| 5 |
JP Morgan Chase
New York
|
-$690 |
NVCN Hedge Fund Activity: Q3 2022 in Review
11 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Neovasc Inc. (NVCN) for Q3 2022, worth a combined $305K — up 67% from $183K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of NVCN and 1 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $21.8K. The largest seller was UBS Group, cutting an estimated $15.7K.
- 11 institutional investors held Neovasc Inc. (NVCN) as of Q3 2022, down from 12 in Q2 2022.
- Funds reported $305K of Neovasc Inc. stock for Q3 2022, up 67% quarter-over-quarter.
- 1 fund opened new Neovasc Inc. positions in Q3 2022 and 2 closed out, a net change of -1 holder.
- The largest Neovasc Inc. buyer in Q3 2022 was Morgan Stanley, an estimated $21.8K added.
- The largest Neovasc Inc. seller in Q3 2022 was UBS Group, an estimated $15.7K sold.
Based on aggregated 13F filings for Q3 2022.